Reesha Solanki
Overview
Explore the profile of Reesha Solanki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson R, Wostear F, Solanki R, Steward O, Bradford A, Morris C, et al.
J Cell Sci
. 2024 Sep;
137(21).
PMID: 39301761
During ageing, the extracellular matrix of the aortic wall becomes more rigid. In response, vascular smooth muscle cells (VSMCs) generate enhanced contractile forces. Our previous findings demonstrate that VSMC volume...
2.
Johnson R, Solanki R, Wostear F, Ahmed S, Taylor J, Rees J, et al.
Br J Pharmacol
. 2023 Dec;
181(11):1576-1595.
PMID: 38044463
Background And Purpose: Decreased aortic compliance is a precursor to numerous cardiovascular diseases. Compliance is regulated by the rigidity of the aortic wall and the vascular smooth muscle cells (VSMCs)....
3.
Ahmed S, Johnson R, Solanki R, Afewerki T, Wostear F, Warren D
Front Pharmacol
. 2022 Feb;
13:836710.
PMID: 35153800
Vascular smooth muscle cells (VSMCs) are the predominant cell type in the medial layer of the aortic wall and normally exist in a quiescent, contractile phenotype where actomyosin-derived contractile forces...
4.
Johnson R, Solanki R, Warren D
Biophys Rev
. 2021 Nov;
13(5):757-768.
PMID: 34745374
Arterial smooth muscle cells (ASMCs), the predominant cell type within the arterial wall, detect and respond to external mechanical forces. These forces can be derived from blood flow (i.e. pressure...
5.
Pohjolainen L, Easton J, Solanki R, Ruskoaho H, Talman V
Front Pharmacol
. 2021 Feb;
11:553852.
PMID: 33584253
Hypertrophy of cardiomyocytes (CMs) is initially a compensatory mechanism to cardiac overload, but when prolonged, it leads to maladaptive myocardial remodeling, impairing cardiac function and causing heart failure. A key...